Chronic Obstructive Pulmonary Disease - Treatment Options, Symptoms, Causes & Diagnosis from MedifocusHealth

Chronic Obstructive Pulmonary Disease > What Your Doctor is Reading About Chronic Obstructive Pulmonary Disease > Review Articles

Review Articles

1. Ventilatory management in patients with chronic airflow obstruction.

Author: Koh Y;
Institution: Division of Pulmonary and Critical Care Medicine, University of Ulsan College of Medicine, Asan Medical Center, 388-1 Pungnap Dong Songpa-Ku, Seoul 138-736, Korea. yskoh@amc.seoul.kr
Journal: Crit Care Clin. 2007 Apr;23(2):169-81, viii.
Abstract URL: Click here to view abstract

2. Exacerbations of chronic obstructive pulmonary disease: when are antibiotics indicated? A systematic review.

Author: Puhan MA; Vollenweider D; Latshang T; Steurer J; Steurer-Stey C;
Institution: Horten Centre, University Hospital of Zurich, Postfach Nord, Zurich, Switzerland. milo.puhan@usz.ch
Journal: Respir Res. 2007 Apr 4;8:30.
Abstract URL: Click here to view abstract

3. The impact of severe exacerbations on quality of life and the clinical course of chronic obstructive pulmonary disease.

Author: Niewoehner DE;
Institution: University of Minnesota, Minneapolis, Minnesota, USA. niewo001@tc.umn.edu
Journal: Am J Med. 2006 Oct;119(10 Suppl 1):38-45.
Abstract URL: Click here to view abstract

4. The role of patient-centered outcomes in the course of chronic obstructive pulmonary disease: how long-term studies contribute to our understanding.

Author: Tashkin DP;
Institution: Division of Pulmonary and Critical Care Medicine, Department of Medicine, David Geffen School of Medicine at UCLA, University of California-Los Angeles, Los Angeles, California 90095-1690, USA. dtashkin@mednet.ucla.edu
Journal: Am J Med. 2006 Oct;119(10 Suppl 1):63-72.
Abstract URL: Click here to view abstract

5. Is airway inflammation in chronic obstructive pulmonary disease (COPD) a risk factor for cardiovascular events?

Author: Calverley PM; Scott S;
Institution: Clinical Science Centre, University Hospital Aintree, Liverpool, UK. pmacal@liverpool.ac.uk
Journal: COPD. 2006 Dec;3(4):233-42.
Abstract URL: Click here to view abstract

6. N-acetylcysteine and exacerbations of chronic obstructive pulmonary disease.

Author: Sutherland ER; Crapo JD; Bowler RP;
Institution: Department of Medicine, National Jewish Medical and Research Center, Denver, Colorado, USA. sutherlande@njc.org
Journal: COPD. 2006 Dec;3(4):195-202.
Abstract URL: Click here to view abstract

7. Transplantation in chronic obstructive pulmonary disease.

Author: Patel N; Criner GJ;
Institution: Division of Pulmonary and Critical Care Medicine, Temple University School of Medicine, Philadelphia, Pennsylvania 19140, USA. pateln@tuhs.temple.edu
Journal: COPD. 2006 Aug;3(3):149-62.
Abstract URL: Click here to view abstract

8. Clinical safety of long-acting beta2-agonist and inhaled corticosteroid combination therapy in COPD.

Author: Decramer M; Ferguson G;
Institution: Respiratory Division University Hospital, Katholieke Universiteit Leuven, Leuven, Belgium. marc.decramer@uz.kuleuven.be
Journal: COPD. 2006 Aug;3(3):163-71.
Abstract URL: Click here to view abstract

9. Diagnostic and therapeutic challenges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure.

Author: Le Jemtel TH; Padeletti M; Jelic S; Le Jemtel TH; Padeletti M; Jelic S;
Institution: Division of Cardiology, Tulane University, New Orleans, Louisiana 70112-2699, USA. lejemtel@tulane.edu
Journal: J Am Coll Cardiol. 2007 Jan 16;49(2):171-80. Epub 2006 Dec 29.
Abstract URL: Click here to view abstract

10. Effectiveness of chronic obstructive pulmonary disease-management programs: systematic review and meta-analysis.

Author: Peytremann-Bridevaux I; Staeger P; Bridevaux PO; Ghali WA; Burnand B; Peytremann-Bridevaux I; Staeger P; Bridevaux PO; Ghali WA; Burnand B; Peytremann-Bridevaux I; Staeger P; Bridevaux PO; Ghali WA; Burnand B;
Institution: Institute of Social and Preventive Medicine, Healthcare Evaluation Unit, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland. Isabelle.Peytremann-Bridevaux@chuv.ch
Journal: Am J Med. 2008 May;121(5):433-443.e4.
Abstract URL: Click here to view abstract

11. Drugs (including oxygen) in severe COPD.

Author: Albert P; Calverley PM; Albert P; Calverley PM; Albert P; Calverley PM;
Institution: Division of Infection and Immunity, Clinical Sciences Centre, University Hospital Aintree, Lower Lane, Liverpool L9 7AL, UK.
Journal: Eur Respir J. 2008 May;31(5):1114-24.
Abstract URL: Click here to view abstract

12. Roflumilast: an oral, once-daily selective PDE-4 inhibitor for the management of COPD and asthma.

Author: Field SK; Field SK; Field SK;
Institution: Foothills Medical Centre and Tuberculosis Services, Calgary Health Region, Health Science Centre, 3330 Hospital Dr NW, Calgary, Alberta, T2N 4N1, Canada. sfield@ucalgary.ca
Journal: Expert Opin Investig Drugs. 2008 May;17(5):811-8.
Abstract URL: Click here to view abstract

13. Update in chronic obstructive pulmonary disease 2007.

Author: MacNee W; MacNee W; MacNee W;
Institution: ELEGI Colt Research Labs, University of Edinburgh/MRC Centre for Inflammation Research, The Queen's Medical Research Institute, Edinburgh, United Kingdom. w.macnee@ed.ac.uk
Journal: Am J Respir Crit Care Med. 2008 Apr 15;177(8):820-9.

14. Clinical inquiries: When are antibiotics indicated for acute COPD exacerbations?

Author: Balser E; Neher JO; Safranek S; Taraday J;
Institution: Valley Medical Center Family Medicine Residency, Renton, WA, USA.
Journal: J Fam Pract. 2006 Dec;55(12):1079-80.
Abstract URL: Click here to view abstract

15. Use of helium-oxygen mixture in adult patients presenting with exacerbations of asthma and chronic obstructive pulmonary disease: a systematic review.

Author: Colebourn CL; Barber V; Young JD;
Institution: Intensive Care Medicine and General Medicine, John Radcliffe Hospital, Headley Way, Oxford OX3 9DU, UK. ccolebourn@doctors.org.uk
Journal: Anaesthesia. 2007 Jan;62(1):34-42.
Abstract URL: Click here to view abstract

16. Contemporary management of acute exacerbations of COPD: a systematic review and metaanalysis.

Author: Quon BS; Gan WQ; Sin DD; Quon BS; Gan WQ; Sin DD; Quon BS; Gan WQ; Sin DD;
Institution: Department of Medicine, Respiratory Division, University of British Columbia, Vancouver, BC, Canada.
Journal: Chest. 2008 Mar;133(3):756-66.
Abstract URL: Click here to view abstract

17. Why act early in COPD?

Author: Wesseling GJ; van Schayck CP;
Institution: Dept. of Respiratory Diseases, Care and Public Health Research Institute. Maastricht University Medical Center, Maastricht, the Netherlands. g.wesseling@lung.azm.nl
Journal: Monaldi Arch Chest Dis. 2006 Sep;65(3):152-9.

18. COPD as a lung disease with systemic consequences--clinical impact, mechanisms, and potential for early intervention.

Author: Decramer M; Rennard S; Troosters T; Mapel DW; Giardino N; Mannino D; Wouters E; Sethi S; Cooper CB; Decramer M; Rennard S; Troosters T; Mapel DW; Giardino N; Mannino D; Wouters E; Sethi S; Cooper CB; Decramer M; Rennard S; Troosters T; Mapel DW; Giardino N; Mannino D; Wouters E; Sethi S; Cooper CB;
Institution: Respiratory Division and Department of Rehabilitation Science, University Hospital, Katholieke Universiteit, Leuven, Belgium. (marc.decramer@uz.kuleuven.ac.be
Journal: COPD. 2008 Aug;5(4):235-56.
Abstract URL: Click here to view abstract

19. The new genetics and chronic obstructive pulmonary disease.

Author: Kalsheker N; Chappell S; Kalsheker N; Chappell S; Kalsheker N; Chappell S;
Institution: Division of Clinical Chemistry, Molecular Medical Sciences Institute of Genetics, Queens Medical Centre, University of Nottingham, Nottingham, UK. noor.kalsheker@nottingham.ac.uk
Journal: COPD. 2008 Aug;5(4):257-64.
Abstract URL: Click here to view abstract

20. Patient adherence in COPD.

Author: Bourbeau J; Bartlett SJ; Bourbeau J; Bartlett SJ; Bourbeau J; Bartlett SJ;
Institution: Montreal Chest Institute, McGill University Health Centre, 3650 St Urbain, Office K1.30, Montreal, Quebec. jean.bourbeau@mcgill.ca
Journal: Thorax. 2008 Sep;63(9):831-8.
Abstract URL: Click here to view abstract

21. Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.

Author: Singh S; Loke YK; Furberg CD; Singh S; Loke YK; Furberg CD; Singh S; Loke YK; Furberg CD;
Institution: Department of Medicine, One Medical Center Blvd, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA. sosingh@wfubmc.edu
Journal: JAMA. 2008 Sep 24;300(12):1439-50.
Abstract URL: Click here to view abstract

22. Where is the supporting evidence for treating mild to moderate chronic obstructive pulmonary disease exacerbations with antibiotics? A systematic review.

Author: Puhan MA; Vollenweider D; Steurer J; Bossuyt PM; Ter Riet G; Puhan MA; Vollenweider D; Steurer J; Bossuyt PM; Ter Riet G; Puhan MA; Vollenweider D; Steurer J; Bossuyt PM; Ter Riet G;
Institution: Horten Centre for Patient-oriented Research and Knowledge Transfer, University of Zurich, Switzerland. milo.puhan@usz.ch
Journal: BMC Med. 2008 Oct 10;6:28.
Abstract URL: Click here to view abstract

23. A review of the GOLD guidelines for the diagnosis and treatment of patients with COPD.

Author: Fromer L; Cooper CB; Fromer L; Cooper CB; Fromer L; Cooper CB;
Institution: Department of Family Medicine, David Geffen School of Medicine, UCLA, Los Angeles, CA 90077, USA. mdwelby@aol.com
Journal: Int J Clin Pract. 2008 Aug;62(8):1219-36. Epub 2008 Jun 28.
Abstract URL: Click here to view abstract

24. Novel long-acting bronchodilators for COPD and asthma.

Author: Cazzola M; Matera MG; Cazzola M; Matera MG; Cazzola M; Matera MG;
Institution: Unit of Respiratory Diseases, Department of Internal Medicine, University of Rome Tor Vergata, Rome, Italy. mario.cazzola@uniroma2.it
Journal: Br J Pharmacol. 2008 Oct;155(3):291-9. Epub 2008 Jul 7.
Abstract URL: Click here to view abstract

25. Anti-TNF-alpha therapies in chronic obstructive pulmonary diseases.

Author: Antoniu SA; Mihaltan F; Ulmeanu R; Antoniu SA; Mihaltan F; Ulmeanu R; Antoniu SA; Mihaltan F; Ulmeanu R;
Institution: 'Gr.T.Popa' University of Medicine and Pharmacy Iasi, Division of Pulmonary Disease, Pulmonary Disease University Hospital, 30 Dr I Cihac Street, 700115 Iasi, Romania. sabina.antonela.antoniu@pneum.umfiasi.ro
Journal: Expert Opin Investig Drugs. 2008 Aug;17(8):1203-11.
Abstract URL: Click here to view abstract

26. Integrating palliative care in severe chronic obstructive lung disease.

Author: Hardin KA; Meyers F; Louie S; Hardin KA; Meyers F; Louie S; Hardin KA; Meyers F; Louie S;
Institution: Department of Internal Medicine, UCD Health System Pulmonary Rehabilitation Program, University of California, Davis, Sacramento, CA 95817, USA.
Journal: COPD. 2008 Aug;5(4):207-20.
Abstract URL: Click here to view abstract

27. Inhaled corticosteroids in obstructive airway disease.

Author: Phua GC; Macintyre NR; Phua GC; Macintyre NR; Phua GC; Macintyre NR;
Institution: Division of Pulmonary, Allergy, and Critical Care, Department of Medicine, Duke University Medical Center, Durham NC 27710, USA.
Journal: Respir Care. 2007 Jul;52(7):852-8.
Abstract URL: Click here to view abstract

28. Preventing chronic obstructive pulmonary disease: what is known and what needs to be done to make a difference to the patient?

Author: Wise RA; Tashkin DP; Wise RA; Tashkin DP; Wise RA; Tashkin DP;
Institution: Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21224, USA. rwise@welchlink.welch.jhu.edu
Journal: Am J Med. 2007 Aug;120(8 Suppl 1):S14-22.
Abstract URL: Click here to view abstract

29. Optimizing treatment of chronic obstructive pulmonary disease: an assessment of current therapies.

Author: Wise RA; Tashkin DP; Wise RA; Tashkin DP; Wise RA; Tashkin DP;
Institution: Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21224, USA. rwise@welchlink.welch.jhu.edu
Journal: Am J Med. 2007 Aug;120(8 Suppl 1):S4-13.
Abstract URL: Click here to view abstract

30. What have we learned from large drug treatment trials in COPD?

Author: Calverley PM; Rennard SI; Calverley PM; Rennard SI; Calverley PM; Rennard SI;
Institution: Division of Infection and Immunity, Clinical Sciences Centre, University Hospital Aintree, Liverpool, UK. pmacal@liverpool.ac.uk
Journal: Lancet. 2007 Sep 1;370(9589):774-85.
Abstract URL: Click here to view abstract

31. COPD exacerbations: defining their cause and prevention.

Author: Wedzicha JA; Seemungal TA; Wedzicha JA; Seemungal TA; Wedzicha JA; Seemungal TA;
Institution: Academic Unit of Respiratory Medicine, Royal Free and University College Medical School; University College London, UK. j.a.wedzicha@medsch.ucl.ac.uk
Journal: Lancet. 2007 Sep 1;370(9589):786-96.
Abstract URL: Click here to view abstract

32. Small-molecule inhibitors of PDE-IV and -VII in the treatment of respiratory diseases and chronic inflammation.

Author: Vijayakrishnan L; Rudra S; Eapen MS; Dastidar S; Ray A; Vijayakrishnan L; Rudra S; Eapen MS; Dastidar S; Ray A; Vijayakrishnan L; Rudra S; Eapen MS; Dastidar S; Ray A;
Institution: Ranbaxy Laboratories Ltd, Department of Pharmacology, New Drug Discovery Research (R & D III), Plot No. 20, Sector-18, Gurgaon-122 001, India. Lalitha.vijayakrishnan@ranbaxy.com
Journal: Expert Opin Investig Drugs. 2007 Oct;16(10):1585-99.
Abstract URL: Click here to view abstract

33. Malnutrition in chronic obstructive pulmonary disease.

Author: Schwartz DB;
Institution: Providence Saint Joseph Medical Center, 501 S. Buena Vista, Burbank, CA 91505, USA.
Journal: Respir Care Clin N Am. 2006 Dec;12(4):521-31.
Abstract URL: Click here to view abstract

34. Improved outcomes in patients with chronic obstructive pulmonary disease treated with salmeterol compared with placebo/usual therapy: results of a meta-analysis.

Author: Stockley RA; Whitehead PJ; Williams MK;
Institution: Queen Elizabeth Hospital, Birmingham, UK. r.a.stockley@bham.ac.uk
Journal: Respir Res. 2006 Dec 29;7:147.
Abstract URL: Click here to view abstract

35. Use of inhaled anticholinergic agents in obstructive airway disease.

Author: Restrepo RD; Restrepo RD; Restrepo RD;
Institution: Department of Respiratory Care, The University of Texas Health Science Center, 7703 Floyd Curl Drive, Mail Code 6248, San Antonio, TX 78229, USA. restrepor@uthscsa.edu
Journal: Respir Care. 2007 Jul;52(7):833-51.
Abstract URL: Click here to view abstract

36. Approach to chronic obstructive pulmonary disease in primary care.

Author: Todd DC; McIvor RA; Pugsley SO; Cox G; Todd DC; McIvor RA; Pugsley SO; Cox G; Todd DC; McIvor RA; Pugsley SO; Cox G;
Institution: McMaster University in Hamilton, Ont.
Journal: Can Fam Physician. 2008 May;54(5):706-11.
Abstract URL: Click here to view abstract

37. Safety of long-acting beta-agonists in stable COPD: a systematic review.

Author: Rodrigo GJ; Nannini LJ; Rodriguez-Roisin R; Rodrigo GJ; Nannini LJ; Rodriguez-Roisin R; Rodrigo GJ; Nannini LJ; Rodriguez-Roisin R;
Institution: Departamento de Emergencia, Hospital Central de las Fuerzas Armadas, Av. 8 de Octubre 3020, Montevideo 11600, Uruguay. gurodrig@adinet.com.uy
Journal: Chest. 2008 May;133(5):1079-87.
Abstract URL: Click here to view abstract

38. Systematic review of noninvasive positive pressure ventilation in severe stable COPD.

Author: Kolodziej MA; Jensen L; Rowe B; Sin D; Kolodziej MA; Jensen L; Rowe B; Sin D; Kolodziej MA; Jensen L; Rowe B; Sin D;
Institution: Dept of Pulmonary Medicine, Faculty of Medicine and Dentistry, University of Alberta Hospitals, University of Alberta, Edmonton, AB, Canada.
Journal: Eur Respir J. 2007 Aug;30(2):293-306. Epub 2007 Apr 25.
Abstract URL: Click here to view abstract

39. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.

Author: Rabe KF; Hurd S; Anzueto A; Barnes PJ; Buist SA; Calverley P; Fukuchi Y; Jenkins C; Rodriguez-Roisin R; van Weel C; Zielinski J; Rabe KF; Hurd S; Anzueto A; Barnes PJ; Buist SA; Calverley P; Fukuchi Y; Jenkins C; Rodriguez-Roisin R; van Weel C; Zielinski J; Rabe KF; Hurd S; Anzueto A; Barnes PJ; Buist SA; Calverley P; Fukuchi Y; Jenkins C; Rodriguez-Roisin R; van Weel C; Zielinski J;
Institution: Leiden University Medical Center, Pulmonology, P.O. Box 9600, NL-2300 RC, Leiden, The Netherlands. k.f.rabe@lumc.nl
Journal: Am J Respir Crit Care Med. 2007 Sep 15;176(6):532-55. Epub 2007 May 16.
Abstract URL: Click here to view abstract

40. In the clinic. Chronic obstructive pulmonary disease.

Author: Littner MR; Littner MR; Littner MR;
Institution
Journal: Ann Intern Med. 2008 Mar 4;148(5):ITC3-1-ITC3-16.

41. ABC of chronic obstructive pulmonary disease. Pharmacological management--oral treatment.

Author: Currie GP; Lee DK; Lipworth BJ;
Institution: Respiratory Unit, Aberdeen Royal Infirmary, Aberdeen.
Journal: BMJ. 2006 Jun 24;332(7556):1497-9.

42. Injectable vaccines for preventing pneumococcal infection in patients with chronic obstructive pulmonary disease.

Author: Granger R; Walters J; Poole PJ; Lasserson TJ; Mangtani P; Cates CJ; Wood-Baker R;
Institution: University of Tasmania, Medicine, GPO Box 252-34, Hobart, Tasmania, Australia.
Journal: Cochrane Database Syst Rev. 2006 Oct 18;(4):CD001390.
Abstract URL: Click here to view abstract

43. Pulmonary rehabilitation for chronic obstructive pulmonary disease.

Author: Lacasse Y; Goldstein R; Lasserson TJ; Martin S;
Institution: Hospital Laval, Centre de Pneumnologie, 2725 Chemin Sainte-Foy, Sainte-Foy, Quebec, Canada. Yves.Lacasse@med.ulaval.ca
Journal: Cochrane Database Syst Rev. 2006 Oct 18;(4):CD003793.
Abstract URL: Click here to view abstract

44. People with chronic obstructive pulmonary disease at the end of life: a review of the literature.

Author: Goodridge D;
Institution: College of Nursing, University of Saskatchewan, Saskatoon, SK, Canada S7N 5E5. donna.goodridge@usask.ca
Journal: Int J Palliat Nurs. 2006 Aug;12(8):390-6.
Abstract URL: Click here to view abstract

45. ABC of chronic obstructive pulmonary disease. Acute exacerbations.

Author: Currie GP; Wedzicha JA;
Institution: Respiratory Unit, Aberdeen Royal Infirmary, Aberdeen.
Journal: BMJ. 2006 Jul 8;333(7558):87-9.

46. ABC of chronic obstructive pulmonary disease. Ventilatory support.

Author: Christie G; Currie GP; Plant P;
Institution: Respiratory Unit, Aberdeen Royal Infirmary, Aberdeen.
Journal: BMJ. 2006 Jul 15;333(7559):138-40.

47. Clinical practice guidelines for managing COPD in a primary care setting.

Author: O'Donoghue DL; Gerbert DA; Herman LM; Larson LW; Leger MM; McNellis R; Ulshafer C; Van Dyke EM;
Institution
Journal: JAAPA. 2006 Aug;19(8):24-5, 29, 56.

48. Promoting quality of life for patients with moderate to severe COPD.

Author: Tinker R; While A;
Institution: Florence Nightingale School of Nursing and Midwifery, King's College London. rosalyn.tinker@kcl.ac.uk
Journal: Br J Community Nurs. 2006 Jul;11(7):278-84.
Abstract URL: Click here to view abstract

49. Impact of chronic obstructive pulmonary disease on quality of life: the role of dyspnea.

Author: Ries AL; Ries AL;
Institution: Department of Medicine, University of California-San Diego, San Diego Medical Center, San Diego, California 92103-8377, USA. aries@ucsd.edu
Journal: Am J Med. 2006 Oct;119(10 Suppl 1):12-20.
Abstract URL: Click here to view abstract

50. The connection between chronic obstructive pulmonary disease symptoms and hyperinflation and its impact on exercise and function.

Author: Cooper CB; Cooper CB;
Institution: Division of Pulmonary and Critical Care Medicine, Department of Medicine, David Geffen School of Medicine at UCLA, University of California-Los Angeles, Los Angeles, California 90095-1690, USA. ccooper@mednet.ucla.edu
Journal: Am J Med. 2006 Oct;119(10 Suppl 1):21-31.
Abstract URL: Click here to view abstract

51. Functional status and quality of life in chronic obstructive pulmonary disease.

Author: Reardon JZ; Lareau SC; ZuWallack R; Reardon JZ; Lareau SC; ZuWallack R;
Institution: Hartford Hospital, Hartford, Connecticut, USA.
Journal: Am J Med. 2006 Oct;119(10 Suppl 1):32-7.
Abstract URL: Click here to view abstract

52. Clinical course of chronic obstructive pulmonary disease: review of therapeutic interventions.

Author: Anzueto A; Anzueto A;
Institution: Department of Medicine, University of Texas Health Science Center, San Antonio, Texas, USA. anzueto@uthscsa.edu
Journal: Am J Med. 2006 Oct;119(10 Suppl 1):46-53.
Abstract URL: Click here to view abstract

53. Surrogates of mortality in chronic obstructive pulmonary disease.

Author: Cote CG; Cote CG;
Institution: Bay Pines Veterans Administration Health Care System, Bay Pines, Florida 33744, USA. claudia.cote@med.va.gov
Journal: Am J Med. 2006 Oct;119(10 Suppl 1):54-62.
Abstract URL: Click here to view abstract

54. Tiotropium for stable chronic obstructive pulmonary disease: A meta-analysis.

Author: Barr RG; Bourbeau J; Camargo CA; Ram FS;
Institution: Division of General Medicine, PH-9 East Room 105, Columbia University Medical Centre, 630 West 168th Street, New York, NY 10032, USA. rgb9@columbia.edu
Journal: Thorax. 2006 Oct;61(10):854-62. Epub 2006 Jul 14.
Abstract URL: Click here to view abstract

55. Oxygen therapy in the pre-hospital setting for acute exacerbations of chronic obstructive pulmonary disease.

Author: Austin M; Wood-Baker R;
Institution: University of Tasmania, 656 Sandy Bay Road, Sandy Bay, Tasmania, Australia 7005. maaustin@utas.edu.au
Journal: Cochrane Database Syst Rev. 2006 Jul 19;3:CD005534.
Abstract URL: Click here to view abstract

56. Ipratropium bromide versus long-acting beta-2 agonists for stable chronic obstructive pulmonary disease.

Author: Appleton S; Jones T; Poole P; Pilotto L; Adams R; Lasserson TJ; Smith B; Muhammad J;
Institution: Queen Elizabeth Hospital, Dept. of Medicine, Woodville Rd., Woodville, Adelaide, Australia 5011. sappleto@medicine.adelaide.edu au
Journal: Cochrane Database Syst Rev. 2006 Jul 19;3:CD006101.
Abstract URL: Click here to view abstract

57. ABC of chronic obstructive pulmonary disease. Primary care and palliative care.

Author: Freeman D; Price D;
Institution: Department of General Practice and Primary Care, University of Aberdeen, Foresterhill Health Centre, Aberdeen.
Journal: BMJ. 2006 Jul 22;333(7560):188-90.

58. Herbal medicines for the treatment of COPD: a systematic review.

Author: Guo R; Pittler MH; Ernst E;
Institution: Complementary Medicine, Peninsula Medical School, Universities of Exeter and Plymouth, 25 Victoria Park Road, Exeter EX2 4NT, UK. ruoling.guo@pms.ac.uk
Journal: Eur Respir J. 2006 Aug;28(2):330-8.
Abstract URL: Click here to view abstract

59. Psychiatric considerations in pulmonary disease.

Author: Shanmugam G; Bhutani S; Khan DA; Brown ES; Shanmugam G; Bhutani S; Khan DA; Brown ES; Shanmugam G; Bhutani S; Khan DA; Brown ES;
Institution: Division of Allergy and Immunology, Department of Internal Medicine, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390-8849, USA.
Journal: Psychiatr Clin North Am. 2007 Dec;30(4):761-80.
Abstract URL: Click here to view abstract

60. Systematic review of the chronic care model in chronic obstructive pulmonary disease prevention and management.

Author: Adams SG; Smith PK; Allan PF; Anzueto A; Pugh JA; Cornell JE;
Institution: Department of Medicine, The University of Texas Health Science Center at San Antonio, USA. adamssg@uthscsa.edu
Journal: Arch Intern Med. 2007 Mar 26;167(6):551-61.
Abstract URL: Click here to view abstract

61. Physical diagnosis of chronic obstructive pulmonary disease.

Author: Tokuda Y; Miyagi S; Tokuda Y; Miyagi S; Tokuda Y; Miyagi S;
Institution: Department of Medicine, St. Luke's International Hospital, Tokyo. tokuyasu@orange.ocn.ne.jp
Journal: Intern Med. 2007;46(23):1885-91. Epub 2007 Dec 3.
Abstract URL: Click here to view abstract

62. Physiologic similarities and differences between asthma and chronic obstructive pulmonary disease.

Author: Gelb AF; Zamel N; Krishnan A; Gelb AF; Zamel N; Krishnan A; Gelb AF; Zamel N; Krishnan A;
Institution: Pulmonary Division, Department of Medicine, Lakewood Regional Medical Center, Lakewood, California, USA. afgelb@msn.com
Journal: Curr Opin Pulm Med. 2008 Jan;14(1):24-30.
Abstract URL: Click here to view abstract

63. Pathologic similarities and differences between asthma and chronic obstructive pulmonary disease.

Author: Mauad T; Dolhnikoff M; Mauad T; Dolhnikoff M; Mauad T; Dolhnikoff M;
Institution: Department of Pathology, Sao Paulo University Medical School, Sao Paulo, Brazil. tmauad@usp.br
Journal: Curr Opin Pulm Med. 2008 Jan;14(1):31-8.
Abstract URL: Click here to view abstract

64. Phenotypes of chronic obstructive pulmonary disease.

Author: Friedlander AL; Lynch D; Dyar LA; Bowler RP; Friedlander AL; Lynch D; Dyar LA; Bowler RP; Friedlander AL; Lynch D; Dyar LA; Bowler RP;
Institution: Division of Pulmonary Sciences and Critical Care Medicine, Department of Medicine, University of Colorado at Denver and Health Sciences Center, Denver, CO 80206, USA. Adam.Friedlander@uchsc.edu
Journal: COPD. 2007 Dec;4(4):355-84.
Abstract URL: Click here to view abstract

65. Formoterol dry-powder inhaler for the treatment of asthma and chronic obstructive pulmonary disease.

Author: Prenner BM; Prenner BM; Prenner BM;
Institution: Division of Immunology and Allergy, UCSD College of Medicine Allergy Associates Medical Group, Inc., 6386 Alvarado Court Suite 210, San Diego, California 92120, USA. prenner@aaamg.com
Journal: Expert Opin Pharmacother. 2007 Dec;8(17):3069-84.
Abstract URL: Click here to view abstract

66. Definition, epidemiology and natural history of COPD.

Author: Viegi G; Pistelli F; Sherrill DL; Maio S; Baldacci S; Carrozzi L; Viegi G; Pistelli F; Sherrill DL; Maio S; Baldacci S; Carrozzi L; Viegi G; Pistelli F; Sherrill DL; Maio S; Baldacci S; Carrozzi L;
Institution: CNR Institute of Clinical Physiology, Via Trieste 41, 56126, Pisa, Italy. viegig@ifc.cnr.it
Journal: Eur Respir J. 2007 Nov;30(5):993-1013.
Abstract URL: Click here to view abstract

67. Management of stable chronic obstructive pulmonary disease: a systematic review for a clinical practice guideline.

Author: Wilt TJ; Niewoehner D; MacDonald R; Kane RL; Wilt TJ; Niewoehner D; MacDonald R; Kane RL; Wilt TJ; Niewoehner D; MacDonald R; Kane RL;
Institution: Minnesota Agency for Healthcare Research and Quality Evidence-based Practice Center, Minneapolis Veterans Affairs Medical Center, and University of Minnesota, Minneapolis, Minnesota 55417, USA. tim.wilt@med.va.gov
Journal: Ann Intern Med. 2007 Nov 6;147(9):639-53.
Abstract URL: Click here to view abstract

68. Screening for chronic obstructive pulmonary disease using spirometry: summary of the evidence for the U.S. Preventive Services Task Force.

Author: Lin K; Watkins B; Johnson T; Rodriguez JA; Barton MB; Lin K; Watkins B; Johnson T; Rodriguez JA; Barton MB; Lin K; Watkins B; Johnson T; Rodriguez JA; Barton MB;
Institution: Center for Primary Care, Prevention, and Clinical Partnerships, Agency for Healthcare Research and Quality, Rockville, Maryland 20850, USA. kenneth.lin@ahrq.hhs.gov
Journal: Ann Intern Med. 2008 Apr 1;148(7):535-43. Epub 2008 Mar 3.
Abstract URL: Click here to view abstract

69. Chronic cough due to chronic bronchitis: ACCP evidence-based clinical practice guidelines.

Author: Braman SS;
Institution: Division of Pulmonary and Critical Care Medicine, Rhode Island Hospital, 595 Eddy St, Providence, RI 02903, USA. sidney_braman@brown.edu
Journal: Chest. 2006 Jan;129(1 Suppl):104S-115S.
Abstract URL: Click here to view abstract

70. Practical problems with aerosol therapy in COPD.

Author: Rau JL;
Institution: Cardiopulmonary Care Sciences, Georgia State University, Atlanta, Georgia, USA. joerau@comcast.net
Journal: Respir Care. 2006 Feb;51(2):158-72.
Abstract URL: Click here to view abstract

71. Surgical options for patients with COPD: sorting out the choices.

Author: Benditt JO;
Institution: Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Washington, Seattle, Washington 98195-06522, USA. benditt@u.washington.edu
Journal: Respir Care. 2006 Feb;51(2):173-82.
Abstract URL: Click here to view abstract

72. Anxiety and depression in end-stage COPD.

Author: Hill K; Geist R; Goldstein RS; Lacasse Y; Hill K; Geist R; Goldstein RS; Lacasse Y; Hill K; Geist R; Goldstein RS; Lacasse Y;
Institution: Centre de Pneumologie, Hopital Laval, 2725 Chemin Ste-Foy, Ste-Foy, QC, G1V 4G5, Canada.
Journal: Eur Respir J. 2008 Mar;31(3):667-77.
Abstract URL: Click here to view abstract

73. Smoking: relationship to chronic bronchitis, chronic obstructive pulmonary disease and mortality.

Author: Pelkonen M; Pelkonen M; Pelkonen M; Pelkonen M;
Institution: Department of Pulmonary Diseases, Kuopio University Hospital, Kuopio, Finland. Pelkonen@kuh.fi
Journal: Curr Opin Pulm Med. 2008 Mar;14(2):105-9.
Abstract URL: Click here to view abstract

74. Nasal and sinus involvement in chronic obstructive pulmonary disease.

Author: Kim JS; Rubin BK; Kim JS; Rubin BK; Kim JS; Rubin BK;
Institution: Department of Otolaryngology, Kyungpook National University, Daegu, Korea.
Journal: Curr Opin Pulm Med. 2008 Mar;14(2):101-4.
Abstract URL: Click here to view abstract

75. Prevalence and outcome of severe chronic obstructive pulmonary disease exacerbations caused by multidrug-resistant bacteria.

Author: Nseir S; Ader F; Nseir S; Ader F; Nseir S; Ader F;
Institution: Intensive Care Unit, Calmette Hospital, University Hospital of Lille, Lille, France. s-nseir@chru-lille.fr
Journal: Curr Opin Pulm Med. 2008 Mar;14(2):95-100.
Abstract URL: Click here to view abstract

76. Viral infections in patients with chronic obstructive pulmonary disease.

Author: Varkey JB; Varkey B; Varkey JB; Varkey B; Varkey JB; Varkey B;
Institution: Division of Infectious Diseases, Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA. jay.varkey@duke.edu
Journal: Curr Opin Pulm Med. 2008 Mar;14(2):89-94.
Abstract URL: Click here to view abstract

77. Immunology of asthma and chronic obstructive pulmonary disease.

Author: Barnes PJ; Barnes PJ; Barnes PJ;
Institution: Airway Disease Section, National Heart and Lung Institute, Imperial College London, Dovehouse Street, London SW3 6LY, UK. p.j.barnes@imperial.ac.uk
Journal: Nat Rev Immunol. 2008 Mar;8(3):183-92. Epub 2008 Feb 15.
Abstract URL: Click here to view abstract

78. Short-course antibiotic treatment in acute exacerbations of chronic bronchitis and COPD: a meta-analysis of double-blind studies.

Author: El Moussaoui R; Roede BM; Speelman P; Bresser P; Prins JM; Bossuyt PM; El Moussaoui R; Roede BM; Speelman P; Bresser P; Prins JM; Bossuyt PM; El Moussaoui R; Roede BM; Speelman P; Bresser P; Prins JM; Bossuyt PM;
Institution: Department of Internal Medicine, Division of Infectious Diseases, Tropical Medicine and AIDS and Center for Infection and Immunity Amsterdam (CINIMA), Amsterdam, The Netherlands.
Journal: Thorax. 2008 May;63(5):415-22. Epub 2008 Jan 30.
Abstract URL: Click here to view abstract

79. Pneumococcal vaccination for patients with COPD: current practice and future directions.

Author: Schenkein JG; Nahm MH; Dransfield MT; Schenkein JG; Nahm MH; Dransfield MT; Schenkein JG; Nahm MH; Dransfield MT;
Institution: The University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Journal: Chest. 2008 Mar;133(3):767-74. Epub 2007 Sep 21.
Abstract URL: Click here to view abstract

80. Oxygen supplementation for chronic obstructive pulmonary disease patients during air travel.

Author: Seccombe LM; Peters MJ;
Institution: Department of Thoracic Medicine, Concord Repatriation General Hospital, Sydney, Australia. seccombel@email.cs.nsw.gov.au
Journal: Curr Opin Pulm Med. 2006 Mar;12(2):140-4.
Abstract URL: Click here to view abstract

81. Update in chronic obstructive pulmonary disease 2005.

Author: Fabbri LM; Luppi F; Beghe B; Rabe KF;
Institution: Department of Respiratory Diseases, University of Modena and Reggio Emilia, Via del Pozzo 71, 41100 Modena, Italy. fabbri.leonardo@unimo.it
Journal: Am J Respir Crit Care Med. 2006 May 15;173(10):1056-65.

82. ABC of chronic obstructive pulmonary disease. Definition, epidemiology, and risk factors.

Author: Devereux G;
Institution: Department of Environmental and Occupational Medicine, University of Aberdeen, Aberdeen.
Journal: BMJ. 2006 May 13;332(7550):1142-4.

83. Roflumilast for the treatment of chronic obstructive pulmonary disease.

Author: Antoniu SA;
Institution: Clinic of Pulmonary Disease, 30 Dr I Cihac Street, 700115 Iasi, Romania. sabinaantoniu@excite.com
Journal: Curr Opin Investig Drugs. 2006 May;7(5):412-7.
Abstract URL: Click here to view abstract

84. ABC of chronic obstructive pulmonary disease. Diagnosis.

Author: Currie GP; Legge JS;
Institution: Respiratory Unit, Aberdeen Royal Infirmary, Aberdeen.
Journal: BMJ. 2006 May 27;332(7552):1261-3.

85. Efficacy and safety of inhaled corticosteroids in patients with COPD: a systematic review and meta-analysis of health outcomes.

Author: Gartlehner G; Hansen RA; Carson SS; Lohr KN;
Institution: Cecil G. Sheps Center for Health Services Research, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. gartlehner@schsr.unc.edu
Journal: Ann Fam Med. 2006 May-Jun;4(3):253-62.
Abstract URL: Click here to view abstract

86. Effective management of COPD in primary care - the role of long-acting beta agonist/inhaled corticosteroid combination therapy.

Author: van Schayck CP; Reid J;
Institution: Department of General Practice, University of Maastricht Research Institute CAPHRI, P.O. Box 616, 6200 MD Maastricht, The Netherlands. onno.vanschayck@hag.unimaas.nl
Journal: Prim Care Respir J. 2006 Jun;15(3):143-51. Epub 2006 Apr 11.
Abstract URL: Click here to view abstract

87. ABC of chronic obstructive pulmonary disease.Non-pharmacological management.

Author: Currie GP; Douglas JG;
Institution: Respiratory Unit, Aberdeen Royal Infirmary, Aberdeen.
Journal: BMJ. 2006 Jun 10;332(7554):1379-81.

88. Pharmacological management--inhaled treatment.

Author: Currie GP; Lipworth BJ;
Institution: Respiratory Unit, Aberdeen Royal Infirmary, Aberdeen.
Journal: BMJ. 2006 Jun 17;332(7555):1439-41.

89. Pulmonary rehabilitation in patients undergoing lung-volume reduction surgery.

Author: Bartels MN; Kim H; Whiteson JH; Alba AS;
Institution: Rehabilitation Medicine Department, Columbia University, College of Physicians and Surgeons, New York, NY 10032, USA. mnb4@columbia.edu
Journal: Arch Phys Med Rehabil. 2006 Mar;87(3 Suppl 1):S84-8; quiz S89-90.
Abstract URL: Click here to view abstract

90. Antibiotics for exacerbations of chronic obstructive pulmonary disease.

Author: Ram FS; Rodriguez-Roisin R; Granados-Navarrete A; Garcia-Aymerich J; Barnes NC;
Institution: Massey University - Albany, School of Health Sciences, Private Bag 102 904, North Shore Mail Centre, Auckland, New Zealand. fsfram@yahoo.co.uk
Journal: Cochrane Database Syst Rev. 2006 Apr 19;(2):CD004403.
Abstract URL: Click here to view abstract